Logo image of MGRM

MONOGRAM TECHNOLOGIES INC (MGRM) Stock Fundamental Analysis

NASDAQ:MGRM - Nasdaq - US6097861081 - Common Stock - Currency: USD

2.7  +0.07 (+2.66%)

Fundamental Rating

3

MGRM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. MGRM has a great financial health rating, but its profitability evaluates not so good. MGRM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MGRM has reported negative net income.
In the past year MGRM has reported a negative cash flow from operations.
MGRM had negative earnings in each of the past 5 years.
MGRM had a negative operating cash flow in each of the past 5 years.
MGRM Yearly Net Income VS EBIT VS OCF VS FCFMGRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

MGRM has a Return On Assets of -92.73%. This is in the lower half of the industry: MGRM underperforms 79.06% of its industry peers.
With a Return On Equity value of -113.62%, MGRM is not doing good in the industry: 63.87% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -92.73%
ROE -113.62%
ROIC N/A
ROA(3y)-91.88%
ROA(5y)-104.59%
ROE(3y)-182.06%
ROE(5y)-213.04%
ROIC(3y)N/A
ROIC(5y)N/A
MGRM Yearly ROA, ROE, ROICMGRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MGRM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGRM Yearly Profit, Operating, Gross MarginsMGRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

9

2. Health

2.1 Basic Checks

MGRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MGRM has less shares outstanding than it did 1 year ago.
MGRM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MGRM Yearly Shares OutstandingMGRM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
MGRM Yearly Total Debt VS Total AssetsMGRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 9.84 indicates that MGRM is not in any danger for bankruptcy at the moment.
MGRM's Altman-Z score of 9.84 is amongst the best of the industry. MGRM outperforms 91.62% of its industry peers.
MGRM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.84
ROIC/WACCN/A
WACC9.15%
MGRM Yearly LT Debt VS Equity VS FCFMGRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

MGRM has a Current Ratio of 10.57. This indicates that MGRM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.57, MGRM belongs to the top of the industry, outperforming 93.72% of the companies in the same industry.
MGRM has a Quick Ratio of 10.57. This indicates that MGRM is financially healthy and has no problem in meeting its short term obligations.
MGRM has a better Quick ratio (10.57) than 94.24% of its industry peers.
Industry RankSector Rank
Current Ratio 10.57
Quick Ratio 10.57
MGRM Yearly Current Assets VS Current LiabilitesMGRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

MGRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.61%.
MGRM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)-10.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.68%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 23.04% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-25%
EPS Next 2Y5.36%
EPS Next 3Y9.7%
EPS Next 5Y23.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGRM Yearly Revenue VS EstimatesMGRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
MGRM Yearly EPS VS EstimatesMGRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MGRM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MGRM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGRM Price Earnings VS Forward Price EarningsMGRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGRM Per share dataMGRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.36%
EPS Next 3Y9.7%

More info and screens

0

5. Dividend

5.1 Amount

MGRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONOGRAM TECHNOLOGIES INC

NASDAQ:MGRM (4/23/2025, 4:30:01 PM)

2.7

+0.07 (+2.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)N/A N/A
Inst Owners4.32%
Inst Owner Change0%
Ins Owners22.85%
Ins Owner Change3.71%
Market Cap95.28M
Analysts82.86
Price Target5.81 (115.19%)
Short Float %0.56%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.29%
Min EPS beat(2)-30.72%
Max EPS beat(2)-15.86%
EPS beat(4)1
Avg EPS beat(4)-14.07%
Min EPS beat(4)-30.72%
Max EPS beat(4)10.13%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)14%
EPS NQ rev (1m)-15%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-35.87%
EPS NY rev (3m)-35.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.57
P/tB 6.73
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0
BVpS0.41
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -92.73%
ROE -113.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.88%
ROA(5y)-104.59%
ROE(3y)-182.06%
ROE(5y)-213.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.53%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.57
Quick Ratio 10.57
Altman-Z 9.84
F-Score3
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)32.55%
Cap/Depr(5y)360.85%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.68%
EPS Next Y-25%
EPS Next 2Y5.36%
EPS Next 3Y9.7%
EPS Next 5Y23.04%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.94%
EBIT Next 3Y18.58%
EBIT Next 5Y30.22%
FCF growth 1Y-3.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.14%
OCF growth 3YN/A
OCF growth 5YN/A